President Donald Trump has signed a government funding bill, ending a record 43-day shutdown that caused financial stress for ...
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl), the ...
Company ranked #1 for Onboarding & Continuous Learning and Direct B2B Selling Use Cases in Gartner® Critical Capabilities for ...
Research and Development expenses for the third quarter of 2025 were $13.9 million compared to $11.5 million in the third quarter of 2024. The increase was primarily driven by higher headcount, higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results